These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

236 related items for PubMed ID: 10821713

  • 1. SAR of 9-amino-1,2,3,4-tetrahydroacridine-based acetylcholinesterase inhibitors: synthesis, enzyme inhibitory activity, QSAR, and structure-based CoMFA of tacrine analogues.
    Recanatini M, Cavalli A, Belluti F, Piazzi L, Rampa A, Bisi A, Gobbi S, Valenti P, Andrisano V, Bartolini M, Cavrini V.
    J Med Chem; 2000 May 18; 43(10):2007-18. PubMed ID: 10821713
    [Abstract] [Full Text] [Related]

  • 2. Combined 3D-QSAR, molecular docking, and molecular dynamics study of tacrine derivatives as potential acetylcholinesterase (AChE) inhibitors of Alzheimer's disease.
    Zhou A, Hu J, Wang L, Zhong G, Pan J, Wu Z, Hui A.
    J Mol Model; 2015 Oct 18; 21(10):277. PubMed ID: 26438408
    [Abstract] [Full Text] [Related]

  • 3. Quantitative structure-activity relationship (QSAR) of tacrine derivatives against acetylcholinesterase (AChE) activity using variable selections.
    Jung M, Tak J, Lee Y, Jung Y.
    Bioorg Med Chem Lett; 2007 Feb 15; 17(4):1082-90. PubMed ID: 17158047
    [Abstract] [Full Text] [Related]

  • 4. 3D-QSAR studies on natural acetylcholinesterase inhibitors of Sarcococca saligna by comparative molecular field analysis (CoMFA).
    Zaheer-ul-Haq, Wellenzohn B, Tonmunphean S, Khalid A, Choudhary MI, Rode BM.
    Bioorg Med Chem Lett; 2003 Dec 15; 13(24):4375-80. PubMed ID: 14643329
    [Abstract] [Full Text] [Related]

  • 5. Acetylcholinesterase inhibitors for potential use in Alzheimer's disease: molecular modeling, synthesis and kinetic evaluation of 11H-indeno-[1,2-b]-quinolin-10-ylamine derivatives.
    Rampa A, Bisi A, Belluti F, Gobbi S, Valenti P, Andrisano V, Cavrini V, Cavalli A, Recanatini M.
    Bioorg Med Chem; 2000 Mar 15; 8(3):497-506. PubMed ID: 10732965
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Synthesis, design and biological evaluation of novel highly potent tacrine congeners for the treatment of Alzheimer's disease.
    Hamulakova S, Janovec L, Hrabinova M, Kristian P, Kuca K, Banasova M, Imrich J.
    Eur J Med Chem; 2012 Sep 15; 55():23-31. PubMed ID: 22818849
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Novel tacrine analogs as potential cholinesterase inhibitors in Alzheimer's disease.
    El-Malah A, Gedawy EM, Kassab AE, Salam RM.
    Arch Pharm (Weinheim); 2014 Feb 15; 347(2):96-103. PubMed ID: 24343873
    [Abstract] [Full Text] [Related]

  • 13. Synthesis and Biological Evaluation of New Tacrine Analogues under Microwave Irradiation.
    Alshareef HF, Mohamed HAEH, Salaheldin AM.
    Chem Pharm Bull (Tokyo); 2017 Feb 15; 65(8):732-738. PubMed ID: 28768927
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.